SPC276
Dacomitíníb eða salt eða hýdrat þaraf, þ.á.m. einhýdrat
Status:
VeittApplication date:
10.9.2019Application published:
15.10.2019Grant published:
15.6.2022
Max expiry date:
24.4.2030Next due date:
30.4.2026Medicine name:
VizimproMedicine for children:
No
Timeline
Today
10.9.2019Application
15.10.2019Publication
15.6.2022Registration
24.4.2026Expires
Marketing license
IS authorization number:
EU/1/19/1354/001-003Date:
27.5.2019
Foreign authorization number:
EU/1/19/1354Date:
2.4.2019
Owner
Name:
Warner-Lambert Company LLCAddress:
66 Hudson Boulevard East, New York, NY 10001-2192 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1746999
Annual fees
Number
Paid
Expires
Payer
Number: 1
Paid: 18.3.2025
Expires: 24.4.2026
Payer: Árnason Faktor ehf.